West Pharmaceutical Servi...

NYSE: WST · Real-Time Price · USD
246.42
0.22 (0.09%)
At close: Aug 15, 2025, 3:03 PM

West Pharmaceutical Services Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
131.8M 89.8M 130.1M 136M 111.3M 115.3M 137M 161.3M 155.1M 140M 103M 120.6M 188.5M 173.8M 147.7M 175.6M 187.3M 151.2M
Depreciation & Amortization
40.8M 39.1M 40.7M 40.2M 38.9M 35.6M 35.9M 35.7M 34.1M 31.6M 31.1M 29.8M 30.1M 29.6M 34.4M 30M 28.8M 29.1M
Stock-Based Compensation
7.4M 1.3M 4.3M 5.1M 4.3M 5M 1.4M 5.9M 7.5M 8.5M 6.7M 6M 5.5M 5.5M 10M 11.3M 10.3M 5.9M
Other Working Capital
-100K 100K 23.5M -100K 14.1M -34.6M 26.9M 24.8M -25.3M -46.8M 206M -31.6M -47.5M -50.2M -5.3M -20M -73.6M -94.9M
Other Non-Cash Items
-2.8M -900K -8.5M -1.1M -3.6M -3.1M 14.5M 194.4M -5.9M 4.8M 3M 44.1M -3.5M -7.5M 17.1M -6.8M -8.5M -3.2M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 23.4M -192M 3.7M n/a -30.8M n/a n/a n/a -43.1M n/a 100K 600K
Change in Working Capital
-100K 100K 23.5M -100K 14.1M -34.6M 26.9M 24.8M -25.3M -46.8M 117.8M -31.6M -47.5M -50.2M -5.3M -20M -73.6M -94.9M
Operating Cash Flow
177.1M 129.4M 190.1M 180.1M 165M 118.2M 239.1M 230.1M 169.2M 138.1M 230.8M 168.9M 173.1M 151.2M 160.8M 190.1M 144.4M 88.7M
Capital Expenditures
-75.2M -71.3M -104.9M -81.3M -100.2M -90.6M -108.7M -95.8M -75.4M -82.1M -94.9M -57.8M -66.1M -65.8M -76.5M -65.3M -56.9M -54.7M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.2M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 100K -800K -1M n/a -100K 100K -6.7M n/a 100K -1.3M 100K -2.5M 1.3M n/a 1M 200K
Investing Cash Flow
-75.2M -71.3M -104.8M -82.1M -101.2M -90.6M -108.8M -95.7M -82.1M -82.1M -94.8M -59.1M -66M -68.3M -77.4M -65.3M -55.9M -54.5M
Debt Repayment
-300K -200K -100K -3.5M -23.4M -600K -600K -600K -500K -600K -600K -42.6M -500K -600K -1.1M n/a -500K -600K
Common Stock Repurchased
-500K -136M -54.6M -52.4M -187.2M -272.4M -177.1M -28.1M -174.4M -71.6M 100K -27.5M -28.9M -165.9M -100K -300K -700K -150.8M
Dividend Paid
-15.1M -15.2M -15.3M -14.5M -14.6M -14.7M -14.8M -14M -14.1M -14.1M -14.1M -13.5M -13.1M -13.4M -13.3M -12.6M -12.6M -12.6M
Other Financial Acitivies
1M 4.4M 1.1M 6M 6.9M 16.7M 3M 20.4M 12.2M 15.3M 5.1M 8.4M 6.3M 7.2M 8.3M 7.1M 14.1M 7.6M
Financial Cash Flow
-14.9M -147M -68.9M -64.4M -218.3M -271M -189.5M -22.3M -176.8M -71M -9.5M -75.2M -36.2M -172.7M -6.2M -5.8M 300K -156.4M
Net Cash Flow
105.5M -80.4M -6.3M 44.7M -155.6M -252.1M -44.7M 102.3M -90M -8M 165.3M 10.5M 50.8M -94.9M 74.6M 111.8M 92.5M -131.8M
Free Cash Flow
101.9M 58.1M 85.2M 98.8M 64.8M 27.6M 130.4M 134.3M 93.8M 56M 135.9M 111.1M 107M 85.4M 84.3M 124.8M 87.5M 34M